The nation’s leading doctors groups are in a standoff with federal health officials over vaccines. The conflict intensified ...
Zacks Investment Research on MSN
MRK stock trading above 200- & 50-day SMA for 2 months: Time to buy?
Merck’s MRK stock has been trading above its 50-day and 200-day simple moving averages (SMAs) since early November, ...
Two new Cochrane reviews by UK researchers provide strong, consistent evidence that human papillomavirus (HPV) vaccination ...
Hundreds of studies, including gold-standard clinical trials, challenge Health Secretary Robert F. Kennedy Jr.’s claim that ...
Zacks Investment Research on MSN
Will Soft Gardasil Demand Continue to Dampen Merck's Top Line?
Merck MRK continues to face challenges with Gardasil, its second-largest product, which is a vaccine approved for the prevention of certain cancers caused by human papillomavirus. Though the vaccine’s ...
- In women and girls aged 15 to 25 years receiving human papillomavirus (HPV) vaccination with Cervarix, Gardasil or Gardasil-9, compared with no HPV vaccination, there was a slight reduction in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results